Latest News about Alnylam Pharmaceuticals
Recent news which mentions Alnylam Pharmaceuticals
Vertex shuts down trial of liver drug, spurring a selloff
October 15, 2020
From Business Journals
In a first, Alnylam reports success silencing genes in children
September 30, 2020
From Business Journals
From Business Journals
From Business Journals
Dicerna ropes in Roche on gene-silencing deal worth up to $1.67B
October 31, 2019
From Business Journals
From Business Journals
From Business Journals
From Business Journals
On Rare Disease Day, Alnylam launches patient advocacy grant program
February 27, 2019
From Business Journals
VC firm Atlas ditches JP Morgan conference. Will others follow?
January 14, 2019
From Business Journals
From Business Journals
Alnylam shares take a hit amid sluggish sales of first drug
November 07, 2018
From Business Journals
Drug giant Lilly backs Cambridge's Dicerna in $200M deal
October 28, 2018
From Business Journals
Cambridge's Akcea rebounds with FDA approval of first drug
October 05, 2018
From Business Journals
What you missed on your summer vacation in Mass. biotech news
September 03, 2018
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Dicerna to pay $27M to settle Alnylam trade secrets lawsuit
April 20, 2018
From Business Journals
Biotech leaders want to raise $1M to build a statue of Henri Termeer
January 24, 2018
From Business Journals
Sanofi to buy Bioverativ, Biogen's hemophilia spinout, for $11.6B
January 21, 2018
From Business Journals
J.P. Morgan bars press from key meetings at health care conference, angering investors
December 28, 2017
From Business Journals
Benzinga's Bulls & Bears: Looking Back, Looking Forward
December 24, 2017
From Benzinga
Insiders at these 25 Mass. firms netted $771M in stock sales this fall
December 19, 2017
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Alnylam Pharmaceuticals: Bet or Fold?
September 21, 2017
From Stocks to Watch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.